Advised Alpine Bird Manufacturing on the sale of its 50% limited partnership interest in Action Manufacturing LP (Australasia’s largest vehicle specialiser) to Tourism Holdings Limited.
Advised Clinician Holdings on its latest investment round, raising US$5.4m at a pre-money valuation of more than US$40m.
Advised the investors on the latest investment round for Helius Therapeutics – an additional $15m invested in Series D, (increasing total investment to date to more than $45m).
Advised the lead investor syndicate on the latest investment round for Nyriad Limited which raised in excess of $33m of new equity (inclusive of note conversion).
Advising Covid-19 Vaccine Corporation (and its investors) on capital raising and licensing arrangements ($4.3m invested to date).
ADLSI Commercial Transactions Series Raising Capital from Private Investors or the Crowd SCOPE This paper comprises a selection of articles prepared by Andrew Lewis Law on topics relevant to the above presentation from a legal perspective. It does not cover the full scope of the presentation, but it does cover a number of selected areas […]
Advised Clinician Holdings on its investment round to raise approx. US$2.4m from NZ investors and Australian and Singapore VCs.
Advised Massey University on the sale of its ‘Ferri Pro’ technology (which combats iron deficiency) to Nestle.
Advised the investor consortium in relation to their NZ$15m investment in leading medical cannabis start-up, Helius Therapeutics.
For early stage high growth companies, shares or share options are an important component of the remuneration package for key employees, to ensure they are appropriate incentivised and aligned. The tax considerations have changed and best practice has developed. It is timely to update and refresh the key structural and commercial considerations KEY HIGHLIGHTS Anticipated […]